Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Overweight on Lululemon Athletica, Raises Price Target to $387

Morgan Stanley analyst Alex Straton maintains Lululemon Athletica (NASDAQ:LULU) with a Overweight and raises the price target from $343 to $387.
byBenzinga Newsdesk
December 9, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Morgan Stanley analyst Alex Straton maintains Lululemon Athletica (NASDAQ:LULU) with a Overweight and raises the price target from $343 to $387.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Spero Therapeutics Announces First Patient, First Visit For Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr In Complicated Urinary Tract Infections; Spero Is Entitled To Receive $95M In Development Milestone Payments From GSK Over 2 Years

By Benzinga Newsdesk
January 2, 9:07 AM
Spero Therapeutics, Inc. (NASDAQ:SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and

SPRO